Live from the NIH registry
Studies recruiting near Flint right now
Top 25 of 172 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Ahmed Arif Medical Research Center — Grand Blanc, Michigan (7.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Elite Research Center — Flint, Michigan (0.8 mi)
· Sponsor: Novo Nordisk A/S
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Wright & Filippis x Ottobock.care — Flint, Michigan (0.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
McLaren Proton Therapy Center — Flint, Michigan (0.8 mi)
· Sponsor: Proton Collaborative Group
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Atherosclerosis
Phase 2
Interventional 162 participants sought
Ahmed Arif Medical Research Center (AA MRC LLC ) — Flint, Michigan (0.8 mi)
· Sponsor: Genentech, Inc.
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Elite Research Center — Flint, Michigan (0.8 mi)
· Sponsor: Zucara Therapeutics Inc.
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Elite Clinical Research Center /ID# 256782 — Flint, Michigan (0.8 mi)
· Sponsor: AbbVie
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
McLaren Cancer Institute-Flint — Flint, Michigan (0.8 mi)
· Sponsor: NRG Oncology
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Pyoderma Gangrenosum
Phase 3
Interventional 90 participants sought
Dermatology & Cosmetic Center PLLC - Flint — Flint, Michigan (0.8 mi)
· Sponsor: LEO Pharma
TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma Recurrent
N/A
Interventional 198 participants sought
Karmanos Cancer Institute at McLaren Flint — Flint, Michigan (0.8 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Acute Ischemic Stroke
Phase 3
Interventional 404 participants sought
McLaren Flint — Flint, Michigan (0.8 mi)
· Sponsor: Mercy Health Ohio
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma
Phase 2
Interventional 227 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Flint, Michigan (0.8 mi)
· Sponsor: AstraZeneca
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Aa Mrc Llc — Flint, Michigan (0.8 mi)
· Sponsor: Boehringer Ingelheim
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 335 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Phase 2
Interventional 46 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: Wake Forest University Health Sciences
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Michigan Dermatology Institute - Waterford- Site Number : 8400013 — Waterford, Michigan (26.9 mi)
· Sponsor: Sanofi
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Genesee Cancer and Blood Disease Treatment Center — Flint, Michigan (0.8 mi)
· Sponsor: SWOG Cancer Research Network